“…METHODS: Between 1982 and 2012, 3432 patients having an ACL reconstruction using a patellar tendon graft were enrolled into the study. Exclusion criteria included revisions, bilateral involvement, and osteoarthritis (OA) at the time of surgery. …”
Enlace del recurso
Enlace del recurso

“…Patients had continuous enrollment in the 1-year pre-index (without a diagnosis code of the specific ORC under study) and the 1-year post-index, with ≥ 1 BMI value in the 6-months pre-index. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Patients were required to be aged ≥ 40 years, have ≥ 12 months of pre-index and ≥ 30 days of post-index health plan enrollment, with no diagnosis for asthma, cystic fibrosis, and/or lung cancer at any time from January 1, 2013, to March 31, 2018. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: A retrospective cohort study of patients who were aged ≥ 65 years and had a first (index) CDI diagnosis from January 1, 2010, to December 31, 2016, and continuous enrollment in Medicare Parts A, B, and D during the 12-month pre-index and 12-month post-index periods was conducted. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Control patients were only enrolled if the treating physician was not involved in the care of any patients in the intervention group. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Data were collected from retrospective chart reviews, HCP questionnaires, and web-based patient surveys. Eligible patients enrolled online and completed the Patient Assessment of Constipation-Symptoms, the Work Productivity and Activity Impairment Questionnaire-Specific Health Problem, the EuroQOL 5 Dimensions, and the Global Assessment of Treatment Benefit, Satisfaction, and Willingness to Continue standardized questionnaires. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Follow-up data were obtained from the index date (statin initiation) until the end of continuous enrollment. RESULTS: A total of 541,221 patients were included in the analysis. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Patients were previously naive to insulin and glucagon-like peptide-1 receptor agonists (GLP-1 RAs), were persistent on therapy for ≥ 6 months, and had ≥ 12 months of continuous health plan enrollment after initiation. First treatment intensification (increase in basal insulin dose [of ≥ 10%], addition of bolus insulin, GLP-1 RA, or a new oral antidiabetic drug [OAD]) was assessed among patients in poor glycemic control at 6 months after initiation over the available (minimum ≥ 12-month) follow-up. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Two cohorts were compared: CH (> 2 diagnostic CH claims) and controls (nonheadache patients). All patients were enrolled continuously for ± 12 months from date of first CH claim. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: This retrospective analysis used the MarketScan claims database to identify adults with a first diagnosis of FM (ICD-9-CM code 729.1) between 2009 and 2011 with continuous health plan enrollment for 12 months pre- and post-index. Medications of interest were pregabalin, gabapentin, duloxetine, milnacipran, cyclobenzaprine, and tramadol. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…RESULTS: Of 48,026 identified patients, mean age was 77.9 years; 52.8% were female; 93.0% were MAPD enrolled; 92.5% had Quan-Charlson comorbidity score ≥ 3; and about one quarter (26.0%) had no evidence of HFRx. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…FINDINGS: Of the 243 patients enrolled, 78% were male, 9% had been previously treated for HCV with interferon, and none had pre-defined cirrhosis, although 8% had Fibrosis 4 score (FIB-4) >3.25. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: Texas Medicaid claims data from January 1, 2008, to August 31, 2011, were retrospectively analyzed. Continuously enrolled patients aged 5-63 years with a primary diagnosis of asthma (ICD-9-CM code 493) and with 4 or more prescription claims for any asthma medication in 1 year (persistent asthma) were included. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Using simple random sampling, eligible youth who received HIV care services between August and November 2019 were enrolled in the study. SRHL scores were computed using the HLS-EU index method; and individuals whose scores ranged from 34 to 50 were considered health literate. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…English-speaking postpartum women aged 18 years or above with a live birth and access to a smartphone were eligible for enrollment prior to discharge from delivery hospitalization. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Women aged 18-64 years with ≥ 1 UF claim from January 1, 2010, to December 31, 2014, a claim for a UF-related surgery (hysterectomy, myomectomy, uterine artery embolization [UAE], or ablation) from January 1, 2010, to November 30, 2015, and continuous enrollment for ≥ 1 year presurgery and ≥ 30 days postsurgery qualified for study inclusion. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: A prospective cohort study was done on 274 consecutively enrolled obstetric patients at Fort Portal Regional Referral Hospital (FRRH) from August to November 2022. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND: The University of Florida College of Pharmacy’s Medication Therapy Management Communication and Care Center (UF MTMCCC) provides medication therapy management (MTM) services to patients enrolled in a State of Florida Medicaid Waiver Program: Medicaid for the Aged and Disabled. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Adult patients with an initial VTE diagnosis (index DVT, pulmonary embolism [PE], or both) with at least 12 months of enrollment prior to the index VTE were matched 1:1 with comparison patients without VTE. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The twenty-seven patients enrolled received treatment with either imatinib (12), dasatinib (6), nilotinib (7), bosutinib (1), or interferon (1). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso